Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB526

Introduced
2/11/25  

Caption

Pharmacy Benefit Manager Transparency Act of 2025

Impact

The implications of SB526 on state laws are significant, as the bill clarifies that it will not preempt existing state regulations concerning pharmacy benefit managers. This means that states retain the ability to enforce their own rules and regulations regarding PBMs, potentially leading to increased scrutiny and regulation at both the state and federal levels. The enforcement mechanisms outlined in the bill are designed to empower the Federal Trade Commission (FTC) to act against PBMs that engage in unfair practices, bolstering consumer protections within the pharmaceutical market.

Summary

SB526, known as the Pharmacy Benefit Manager Transparency Act of 2025, aims to establish regulations for pharmacy benefit managers (PBMs) who manage prescription drug benefits for health plans. The bill focuses on prohibiting unfair and deceptive practices by PBMs, particularly regarding the pricing of prescription drugs. It mandates that PBMs must report their transactions transparently, ensuring that any price concessions, discounts, or fees are fully disclosed to health plans, payers, and pharmacies. This transparency is intended to protect consumers from inflated drug prices and hidden fees that might compromise their access to medications.

Contention

Notably, some points of contention surrounding SB526 may arise from the balance of power between state and federal regulations. While the intent is to enhance transparency and protect consumers, stakeholders in the pharmacy and health insurance sectors might view these regulations as cumbersome or as an overreach of federal authority into what they see as a market better governed by state law. Additionally, the mandatory reporting requirements may draw criticism from PBMs, who argue that such regulations could impede their operational efficiencies and the ability to negotiate prices effectively.

Congress_id

119-S-526

Policy_area

Health

Introduced_date

2025-02-11

Companion Bills

No companion bills found.

Previously Filed As

US SB127

Pharmacy Benefit Manager Transparency Act of 2023

US SB1339

Pharmacy Benefit Manager Reform Act

US HB2679

Pharmacy Benefits Manager Accountability Act

US HB10362

To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.

US HB2816

Pharmacy Benefit Manager Sunshine and Accountability Act

US SB5503

A bill to prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.

US SB1131

Drug Price Transparency Act of 2023

US HB7717

To amend title XI of the Social Security Act to enhance pharmacy benefit manager transparency requirements.

US HB7535

Prescription Drug Supply Chain Pricing Transparency Act

US HB6283

DRUG Act Delinking Revenue from Unfair Gouging Act

Similar Bills

US HB9096

Pharmacists Fight Back Act

US HB10362

To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.

US HB8261

Preserving Telehealth, Hospital, and Ambulance Access Act

US HB4507

Transparency in Coverage Act

US HB2450

Prescription Drug Transparency and Affordability Act

US SB927

Protecting Pharmacies in Medicaid Act

US HB1768

Lower Costs for Everyday Americans Act Nationwide Consumer and Fuel Retailer Choice Act Recycling and Composting Accountability Act SUPPORT for Patients and Communities Reauthorization Act of 2025 American Music Tourism Act Deploying American Blockchains Act

US HB8848

Affordable and Safe Prescription Drug Importation Act of 2024